Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael L Pulsipher, MD
Children's Hospital Los Angeles
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Ann & Robert H. Lurie Children'S Hospital
Chicago, Illinois, United States
- Washington University, St. Louis
St Louis, Missouri, United States
- New York Medical College
Valhalla, New York, United States
- Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- University of Utah
Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Center
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Aug 2021
- Primary completion
- 31 May 2026
- Completion
- 31 May 2028
- Last update posted
- 4 May 2025
- Registered enrollment
- 30
- Registry id
- NCT04836390
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.